Stockreport

BioAge Labs Highlights BGE-102 Catalysts, DME Study Plans and $285M Cash at Needham Conference [Yahoo! Finance]

BioAge Labs, Inc.  (BIOA) 
Last bioage labs, inc. earnings: 8/3 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.bio-amber.com
PDF 90–98% suppression of IL-1ß and a substantial proportion of participants in the 120 mg obese cohort reaching hs-CRP below 1 mg/L BioAge plans mid-year proof-of-concept [Read more]